1998至2018年美国妊娠期丙型肝炎感染患病率及母婴结局趋势
该横断面研究利用美国医疗费用与利用项目全国住院样本,分析1998至2018年超过7000万例住院分娩或自然流产数据。结果显示,丙肝阳性孕妇占0.20%(95%CI 0.19%-0.21%),以白人、低收入、有烟草/酒精/阿片类使用史者居多。研究期间丙肝阳性妊娠患病率增加16倍,2018年达5.3/1000例妊娠(95%CI 4.9-5.7)。丙肝阳性与剖宫产、早产、胎儿生长不良及胎儿窘迫的比值升高相关,但与妊娠期糖尿病、子痫前期、子痫或死产无显著差异。作者认为这些数据可能支持近期关于每次妊娠均进行丙肝普遍筛查的建议。
要点
- 1998至2018年美国住院分娩中丙肝阳性孕妇患病率增加16倍,2018年达5.3/1000例妊娠(95%CI 4.9-5.7)。
- 丙肝阳性孕妇中白人占77.4%(95%CI 76.1%-78.6%),低收入者占40.0%(95%CI 38.6%-41.5%),有阿片类使用史者占28.9%(95%CI 27.3%-30.6%)。
- 丙肝阳性与剖宫产、早产、胎儿生长不良及胎儿窘迫的比值升高相关,但与妊娠期糖尿病、子痫前期、子痫或死产无显著差异。
- 年龄别患病率增加幅度从3倍(41-50岁)到31倍(21-30岁)不等。
- 作者认为这些数据可能支持近期关于每次妊娠均进行丙肝普遍筛查的建议。
适用人群与场景
- 美国全国住院样本中住院分娩或自然流产的孕妇,数据覆盖1998至2018日历年。
研究设计与关键结果
- 研究类型为横断面研究,使用美国医疗费用与利用项目全国住院样本,1998至2018年超过7000万例住院分娩或自然流产。
- 丙肝阳性孕妇137259例,占0.20%(95%CI 0.19%-0.21%);丙肝阳性孕妇中白人77.4%(95%CI 76.1%-78.6%)、低收入40.0%(95%CI 38.6%-41.5%)、有烟草使用史41.7%(95%CI 40.6%-42.9%)、酒精使用史1.8%(95%CI 1.6%-2.0%)、阿片类使用史28.9%(95%CI 27.3%-30.6%)。
- 丙肝阳性孕妇中位年龄28.0岁(IQR 24.3-32.2),丙肝阴性孕妇中位年龄27.2岁(IQR 22.7-31.8)。
- 研究期间丙肝阳性妊娠患病率增加16倍,2018年达5.3/1000例妊娠(95%CI 4.9-5.7)。
- 年龄别患病率增加幅度从3倍(41-50岁)到31倍(21-30岁)不等。
- 丙肝阳性与剖宫产、早产、胎儿生长不良或胎儿窘迫的比值升高相关;妊娠期糖尿病、子痫前期、子痫或死产无显著差异。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些数据可能支持近期关于每次妊娠均进行丙肝普遍筛查的建议。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Injection drug use is the primary risk factor for hepatitis C virus (HCV) infection in adults. More than one-third of newly reported HCV cases occur in women, particularly among persons aged 20 to 39 years. However, nationally representative data on HCV during pregnancy are limited.
OBJECTIVE: To estimate the temporal trend of HCV-positive pregnancies during the opioid epidemic and identify HCV-associated maternal and perinatal outcomes.
DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional study was performed with data from the US, from calendar year 1998 through 2018. Data analysis was conducted from November 14, 2021, to May 14, 2023. Participants included women during in-hospital childbirth or spontaneous abortion in the National Inpatient Sample of the Healthcare Cost and Utilization Project.
EXPOSURE: Maternal HCV infection.
MAIN OUTCOMES AND MEASURES: The main outcome was the temporal trend, measured as change in the annual prevalence, in the prevalence of HCV positivity among pregnant women since the start of the opioid epidemic in the late 1990s. Secondary outcomes were the associations shown as relative odds between maternal HCV infection and maternal and perinatal adverse events.
RESULTS: During the study period, more than 70 million hospital admissions resulted in childbirth or spontaneous abortion. Among them, 137 259 (0.20%; 95% CI, 0.19%-0.21%) involved mothers with HCV; these individuals were more often White (77.4%; 95% CI, 76.1%-78.6%), low-income (40.0%; 95% CI, 38.6%-41.5%), and likely to have histories of tobacco (41.7%; 95% CI, 40.6%-42.9%), alcohol (1.8%; 95% CI, 1.6%-2.0%), and opioid (28.9%; 95% CI, 27.3%-30.6%) use compared with HCV-negative mothers. The median age of women with HCV was 28.0 (IQR, 24.3-32.2) years, and the median age of HCV-negative women was 27.2 (IQR, 22.7-31.8) years. The prevalence of HCV-positive pregnancies increased 16-fold during the study period, reaching 5.3 (95% CI, 4.9-5.7) cases per 1000 pregnancies in 2018. Age-specific prevalence increases ranged from 3-fold (age, 41-50 years) to 31-fold (age, 21-30 years). Higher odds of cesarean delivery, preterm labor, poor fetal growth, or fetal distress were associated with HCV-positivity during pregnancy. However, no significant differences were observed in gestational diabetes, preeclampsia, eclampsia, or stillbirths.
CONCLUSIONS AND RELEVANCE: In this cross-sectional study, the prevalence of HCV-positive pregnancies increased markedly, and maternal HCV infection was associated with increased risks for adverse perinatal outcomes. These data may support recent recommendations for universal HCV screening with each pregnancy.
参考来源
- Chen PH, Johnson L, Limketkai BN, et al. Trends in the Prevalence of Hepatitis C Infection During Pregnancy and Maternal-Infant Outcomes in the US, 1998 to 2018. JAMA Netw Open. 2023. PMID: 37477918. doi:10.1001/jamanetworkopen.2023.24770
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。